Company profile for Marizyme

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Marizyme is an integrated life sciences company dedicated to the acquisition, development and commercialization of therapies, devices and related products that maintain cellular viability and support metabolism, thereby promoting cellular health and proper function.Our daily focus is cost effectively commercializing the life science assets that we have acquired, seeking partnerships for commercialization of assets where approp...
Marizyme is an integrated life sciences company dedicated to the acquisition, development and commercialization of therapies, devices and related products that maintain cellular viability and support metabolism, thereby promoting cellular health and proper function.Our daily focus is cost effectively commercializing the life science assets that we have acquired, seeking partnerships for commercialization of assets where appropriate, and identifying new assets that fit well within portfolio and corporate strategy.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
555 Heritage Drive, Ste. 205 Jupiter, FL 33458
Telephone
Telephone
(561) 935-9955
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/04/01/3053296/0/en/Qualigen-seeks-to-enter-the-10-Billion-CABG-market-with-non-binding-MOU-to-acquire-Marizyme.html

GLOBENEWSWIRE
01 Apr 2025

https://www.globenewswire.com/news-release/2024/04/16/2863440/0/en/Marizyme-Enters-Into-Co-Development-Agreement-With-Qualigen-Therapeutics-for-the-Commercialization-of-FDA-Cleared-DuraGraft.html

GLOBENEWSWIRE
16 Apr 2024
Marizyme CEO Delivers Business Update
Marizyme CEO Delivers Business Update

23 Oct 2023

// GLOBENEWSWIRE

https://www.globenewswire.com//news-release/2023/10/23/2764767/0/en/Marizyme-CEO-Delivers-Business-Update.html

GLOBENEWSWIRE
23 Oct 2023

https://www.globenewswire.com//news-release/2023/10/06/2756102/0/en/Marizyme-Inc-Announces-FDA-Clearance-for-Flagship-Product-DuraGraft.html

GLOBENEWSWIRE
06 Oct 2023
Marizyme CEO Delivers Business Update
Marizyme CEO Delivers Business Update

03 May 2023

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2023/05/03/2660275/0/en/Marizyme-CEO-Delivers-Business-Update.html

GLOBENEWSWIRE
03 May 2023

https://www.globenewswire.com/news-release/2021/12/23/2357572/0/en/Marizyme-Announces-the-Closing-of-My-Health-Logic-Acquisition-Along-With-Initial-Financing.html

GLOBENEWSWIRE
23 Dec 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty